SCHEMBL6583375

SCHEMBL6583375

COc1cc(N)c(Cl)cc1C(=O)NC1CCN(C(C(=O)C2CCOCC2)C2CCNCC2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 15/20 0.64
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
ADRA2A P08913 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
DRD2 P14416 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
DRD4 P21917 1/20 0.51
ACHE P22303 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
ADRA1A P35348 1/20 0.51
DRD3 P35462 1/20 0.51
OPRK1 P41145 1/20 0.51
HTR2B P41595 1/20 0.51
CHRNA4 P43681 1/20 0.51
HTR3A P46098 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580662 0.95 HTR4 (0.61) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
Fumaric Acid SCHEMBL6768761 0.91 HTR4 (0.56) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6583145 0.88 HTR4 (0.73) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6586524 0.87 HTR4 (0.71) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL7261606 0.87 HTR4 (0.61) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6276809 0.87 HTR4 (0.61) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL7260329 0.87 HTR4 (0.61) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6584476 0.86 HTR4 (0.69) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6590685 0.85 HTR4 (0.68) HTR4CYP1A2CYP3A4ADRA2ACYP2D6
SCHEMBL6584473 0.84 HTR4 (0.67) HTR4CYP1A2CYP3A4ADRA2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362857-B1 (S)-4-amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide for treating gastrointestinal motility disorders DAINIPPON PHARMACEUTICAL CO (JP) 2004-08-11 EP disclosed
WO-2003097638-A1 (S)-4-AMINO-5-CHLORO-2-METHOXY-N-[1-[1-(2-TETRAHYDROFURYLCARBONYL)-4-PIPERIDINYLMETHYL]-4-PIPERIDINYL]BENZAMIDE, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND INTERMEDIATE THEREFOR DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2003-11-27 WO disclosed
EP-1362857-A1 (S)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinymethyl]-4-piperidinyl]benzamide for treating gastrointestinal motility disorders Dainippon Pharmaceutical Co., Ltd. (JP) 2003-11-19 EP disclosed